{
  "experiment_id": "d6cea26cb5660ab7e875ea09e76488cd",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
  "system_instructions": "### Temperature\n\n1.0",
  "temperature": 1.0,
  "thinking": false,
  "timestamp": "2025-11-13T19:25:06.741226",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Neurofibromatosis type 1 microdeletion syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened from a specific genetic variant presentation to the standard diagnosis term from the controlled vocabulary\n\n2. **assay**: \"clinical whole-exome sequencing\" \u2192 \"whole exome sequencing\"\n   - Removed the qualifier \"clinical\" to use the exact controlled terminology value\n\n3. **tumorType**: \"Plexiform neurofibroma (morphologic abnormality)\" \u2192 \"Plexiform Neurofibroma\"\n   - Removed the qualifier \"(morphologic abnormality)\" and corrected capitalization to match the exact controlled vocabulary value",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3016,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 225
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01HwK2WwF5ziiW9hm9FMmTWJ",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Neurofibromatosis type 1 microdeletion syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened from a specific genetic variant presentation to the standard diagnosis term from the controlled vocabulary\n\n2. **assay**: \"clinical whole-exome sequencing\" \u2192 \"whole exome sequencing\"\n   - Removed the qualifier \"clinical\" to use the exact controlled terminology value\n\n3. **tumorType**: \"Plexiform neurofibroma (morphologic abnormality)\" \u2192 \"Plexiform Neurofibroma\"\n   - Removed the qualifier \"(morphologic abnormality)\" and corrected capitalization to match the exact controlled vocabulary value"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3016,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 225
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3016,
          "output_tokens": 225,
          "total_tokens": 3241
        }
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: Broadened from \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\" - the optic pathway glioma is a tumor manifestation associated with NF1 but is not part of the diagnosis enumeration. The primary diagnosis is NF1.\n\n2. **assay**: Narrowed from \"Illumina whole exome sequencing\" to \"whole exome sequencing\" - removed the instrument manufacturer name (Illumina) to use the standard controlled terminology term.\n\n3. **tumorType**: Broadened from \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" - malignant triton tumors are a subtype of MPNST. The controlled terminology uses the broader, standard classification term.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3011,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 262
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_017F5WLKHknvWGvUimjgk9Ra",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: Broadened from \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\" - the optic pathway glioma is a tumor manifestation associated with NF1 but is not part of the diagnosis enumeration. The primary diagnosis is NF1.\n\n2. **assay**: Narrowed from \"Illumina whole exome sequencing\" to \"whole exome sequencing\" - removed the instrument manufacturer name (Illumina) to use the standard controlled terminology term.\n\n3. **tumorType**: Broadened from \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" - malignant triton tumors are a subtype of MPNST. The controlled terminology uses the broader, standard classification term."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3011,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 262
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3011,
          "output_tokens": 262,
          "total_tokens": 3273
        }
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Noonan Syndrome\"\n   - Watson Syndrome is a narrow variant of Noonan Syndrome (Noonan Syndrome with pulmonary valve stenosis). Broadened to the standard general diagnosis.\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - Removed the specific platform vendor name (MGI) to use the standard, broader controlled terminology.\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Removed the specific histological qualifier (\"with Mesenchymal Differentiation\") to match the exact controlled terminology value in the schema.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3010,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 249
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01KcxrghRtHhKN3rLcisauD7",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Noonan Syndrome\"\n   - Watson Syndrome is a narrow variant of Noonan Syndrome (Noonan Syndrome with pulmonary valve stenosis). Broadened to the standard general diagnosis.\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - Removed the specific platform vendor name (MGI) to use the standard, broader controlled terminology.\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Removed the specific histological qualifier (\"with Mesenchymal Differentiation\") to match the exact controlled terminology value in the schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3010,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 249
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3010,
          "output_tokens": 249,
          "total_tokens": 3259
        }
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened the narrow familial spinal variant to the standard NF1 diagnosis term from the controlled vocabulary\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - Broadened the specific MRI technique (open MRI) to the more general standard term \"conventional MRI\" from the controlled vocabulary\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary value \"Unknown\" (capitalized as specified in the schema)",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2998,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 205
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01YSdZjVZLvSWqoJdzXRWnGf",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened the narrow familial spinal variant to the standard NF1 diagnosis term from the controlled vocabulary\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - Broadened the specific MRI technique (open MRI) to the more general standard term \"conventional MRI\" from the controlled vocabulary\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary value \"Unknown\" (capitalized as specified in the schema)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2998,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 205
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2998,
          "output_tokens": 205,
          "total_tokens": 3203
        }
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: No change needed - \"Not Applicable\" is already a valid controlled term.\n\n2. **assay**: Broadened \"immunohistochemistry of skin\" to \"immunohistochemistry\" - the exact controlled terminology value. The tissue specification (\"of skin\") is removed as it's a narrowing modifier not part of the standard assay name.\n\n3. **tumorType**: Corrected \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - the exact controlled terminology value. The histological descriptor \"storiform\" is removed as the standard term is simply \"Cutaneous Neurofibroma\".",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2998,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 203
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01UDjrn7ag1ecZsPZ1GqjB9a",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: No change needed - \"Not Applicable\" is already a valid controlled term.\n\n2. **assay**: Broadened \"immunohistochemistry of skin\" to \"immunohistochemistry\" - the exact controlled terminology value. The tissue specification (\"of skin\") is removed as it's a narrowing modifier not part of the standard assay name.\n\n3. **tumorType**: Corrected \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - the exact controlled terminology value. The histological descriptor \"storiform\" is removed as the standard term is simply \"Cutaneous Neurofibroma\"."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2998,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 203
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2998,
          "output_tokens": 203,
          "total_tokens": 3201
        }
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" \u2192 \"Neurofibromatosis type 1\"\n   - The specific genetic notation refers to NF1 gene deletions on chromosome 17q11.2, which is the underlying cause of Neurofibromatosis type 1. Broadened to the standard clinical diagnosis term.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" \u2192 \"cell viability assay\"\n   - Removed the specific methodology detail (Annexin V staining) to use the broader, standard assay term from the controlled vocabulary.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - Removed the morphological descriptor \"Pedunculated\" to match the exact controlled terminology value. \"Pedunculated\" describes the growth pattern but is not part of the standard enum value.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3020,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 290
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01TaScPSz8JR9YrVUo11TkTf",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" \u2192 \"Neurofibromatosis type 1\"\n   - The specific genetic notation refers to NF1 gene deletions on chromosome 17q11.2, which is the underlying cause of Neurofibromatosis type 1. Broadened to the standard clinical diagnosis term.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" \u2192 \"cell viability assay\"\n   - Removed the specific methodology detail (Annexin V staining) to use the broader, standard assay term from the controlled vocabulary.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - Removed the morphological descriptor \"Pedunculated\" to match the exact controlled terminology value. \"Pedunculated\" describes the growth pattern but is not part of the standard enum value."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3020,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 290
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3020,
          "output_tokens": 290,
          "total_tokens": 3310
        }
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Removed \"with scoliosis\" qualifier. The controlled terminology specifies \"Neurofibromatosis type 1\" as the exact value for diagnosis. Comorbidities like scoliosis should not be included in this field.\n\n2. **assay**: Changed \"anti-tag immunocytochemistry\" to \"immunocytochemistry\". The specific \"anti-tag\" technique descriptor is a narrow variation. The broader, standard controlled term is \"immunocytochemistry\".\n\n3. **tumorType**: Changed \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\". The \"sessile\" descriptor is a narrow specification of growth pattern. The controlled terminology uses the broader term \"Cutaneous Neurofibroma\" (capitalized as specified in the schema).",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3011,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 246
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_014gqUBztsVX1iwkLtancQXS",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Removed \"with scoliosis\" qualifier. The controlled terminology specifies \"Neurofibromatosis type 1\" as the exact value for diagnosis. Comorbidities like scoliosis should not be included in this field.\n\n2. **assay**: Changed \"anti-tag immunocytochemistry\" to \"immunocytochemistry\". The specific \"anti-tag\" technique descriptor is a narrow variation. The broader, standard controlled term is \"immunocytochemistry\".\n\n3. **tumorType**: Changed \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\". The \"sessile\" descriptor is a narrow specification of growth pattern. The controlled terminology uses the broader term \"Cutaneous Neurofibroma\" (capitalized as specified in the schema)."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3011,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 246
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3011,
          "output_tokens": 246,
          "total_tokens": 3257
        }
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"structural MRI\",\n  \"tumorType\": \"Not Applicable\"\n}\n```\n\n**Rationale for corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - The narrow term \"peripheral type\" is an older classification. The standard controlled terminology uses \"Neurofibromatosis type 1\" for the more general condition.\n\n2. **assay**: \"wide bore MRI\" \u2192 \"structural MRI\"\n   - \"Wide bore\" describes a hardware specification rather than the type of MRI scan. The controlled terminology uses \"structural MRI\" as the standard broad term for conventional anatomical MRI imaging.\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Not Applicable\"\n   - This is not a tumor type designation. \"Not Applicable\" is the appropriate controlled value when no tumor type is applicable or identifiable.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2995,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 238
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01DW7QHTrTrXfo6ZWD825k4M",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"structural MRI\",\n  \"tumorType\": \"Not Applicable\"\n}\n```\n\n**Rationale for corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - The narrow term \"peripheral type\" is an older classification. The standard controlled terminology uses \"Neurofibromatosis type 1\" for the more general condition.\n\n2. **assay**: \"wide bore MRI\" \u2192 \"structural MRI\"\n   - \"Wide bore\" describes a hardware specification rather than the type of MRI scan. The controlled terminology uses \"structural MRI\" as the standard broad term for conventional anatomical MRI imaging.\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Not Applicable\"\n   - This is not a tumor type designation. \"Not Applicable\" is the appropriate controlled value when no tumor type is applicable or identifiable."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2995,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 238
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2995,
          "output_tokens": 238,
          "total_tokens": 3233
        }
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Vestibular Schwannoma\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"Vestibular Schwannoma\"\n   - Acoustic neuromas are vestibular schwannomas; this is the standard terminology in the schema\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - Broadened to the standard controlled term; rRNA depletion is a technical detail of the RNA-seq protocol, not a separate assay type\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - Broadened to the standard terminology; acoustic neuroma is a specific type of vestibular schwannoma, and the schema uses the broader \"Schwannoma\" term",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3008,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 232
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01FMp3kogCMC5zBi5LgxzyiF",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Vestibular Schwannoma\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"Vestibular Schwannoma\"\n   - Acoustic neuromas are vestibular schwannomas; this is the standard terminology in the schema\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - Broadened to the standard controlled term; rRNA depletion is a technical detail of the RNA-seq protocol, not a separate assay type\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - Broadened to the standard terminology; acoustic neuroma is a specific type of vestibular schwannoma, and the schema uses the broader \"Schwannoma\" term"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3008,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 232
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3008,
          "output_tokens": 232,
          "total_tokens": 3240
        }
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to \"Neurofibromatosis type 1\" - the specific genetic basis is removed in favor of the standard diagnosis term, with proper capitalization matching the controlled terminology.\n\n2. **assay**: Broadened \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" (a specific commercial product name) to \"cell viability assay\" - the generic assay type from the controlled terminology.\n\n3. **tumorType**: Broadened \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" - removed the histological subtype qualifier to match the standard controlled terminology value.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3041,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 258
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_019bSD4KpnzJsxSahQdgBHNL",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to \"Neurofibromatosis type 1\" - the specific genetic basis is removed in favor of the standard diagnosis term, with proper capitalization matching the controlled terminology.\n\n2. **assay**: Broadened \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" (a specific commercial product name) to \"cell viability assay\" - the generic assay type from the controlled terminology.\n\n3. **tumorType**: Broadened \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" - removed the histological subtype qualifier to match the standard controlled terminology value."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3041,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 258
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3041,
          "output_tokens": 258,
          "total_tokens": 3299
        }
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.7999999999999999,
      "min_score": 0.3333333333333333,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 28.450093507766724,
    "token_usage": {
      "input_tokens": 30108,
      "output_tokens": 2408,
      "total_tokens": 32516
    }
  }
}